Nordicus Share Price
NASDAQ: NORD | Industrials$2.88
+$2.88 (--%) Last updated on 21 Nov, 2026 | 00:05 ISTNordicus Stock Performance
Nordicus Share Price Chart
$0.00$0.00
L
H
About Nordicus
Nordicus Partners Corp specializes in developing breakthrough therapeutics for diseases with unmet medical needs. The Company focuses on acquiring and developing drugs from biotech companies in the Nordics, a region known for its scientists, life sciences ecosystem, and drug discoveries and developments. Its current portfolio includes the preclinical biotechnology companies Orocidin A/S, Bio-Convert A/S, and NoviThera ApS. The Company is dedicated to developing breakthrough therapeutics in diseases with unmet medical needs, starting with oral disorders. It operates in the segment focused on developing medicines supporting oral health.
Nordicus Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $3.69 | $2.88 | -24.21% |
Oct 2026 | $3.82 | $3.80 | N/A |